GlassScriptPhysician profile
William J Stephan
NPI 1851344931
$7,433.67
in general payments reported to CMS, 2019-2025
12 companies · $417 in 2025
The $417 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,459 · 2020: $600 · 2021: $12.61 · 2022: $307 · 2023: $271 · 2024: $4,367 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,291 · Food and Beverage: $1,635 · Entertainment: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,291.36 |
| Food and Beverage | $1,634.61 |
| Entertainment | $129.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,155.81 | 2020-2025 | Evoque, Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $1,838.15 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Medtronic Vascular, INC. | $1,234.38 | 2019 | |
| Opsens INC. | $337.96 | 2022-2023 | Optowire |
| Cardiva Medical, INC. | $321.58 | 2024-2025 | Savvywire, Optowire, Other |
| Medtronic, INC. | $307.60 | 2022-2025 | Corevalve Evolut R, Symplicity G3 |
| Boston Scientific Corporation | $99.99 | 2019 | |
| Amgen INC. | $36.15 | 2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $32.66 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.52 | 2022-2023 | Eliquis |
| Surmodics, INC. | $21.61 | 2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Pounce Thrombectomy System |
| Adagio Medical, INC. | $18.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Stephan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.